Clinical Trial Update: Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating DHA for retinitis pigmentosa patients receiving Vitamin A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• DHA (Docosahexaenoic acid)

Snippet

Sponsor: Carol Weigel DiFranco | Conditions: Retinitis Pigmentosa | Phase 3 | Status: COMPLETED